Atacicept Terminated Phase 2 Trials for Systemic Lupus Erythematosus (SLE) Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Terminated | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT02070978 | Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) |